Metropolitan Life Insurance Company (MetLife)’s Texas Instruments TXN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TXN Stock Details TXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-36,674	Closed	-$6.39M	–	1976
2024 Q1	$6.39M	Sell	36,674 -294	-0.8%	-$49K	0.28%	60
2023 Q4	$6.3M	Sell	36,968 -599	-2%	-$92.8K	0.3%	55
2023 Q3	$5.97M	Sell	37,567 -1,988	-5%	-$339K	0.31%	53
2023 Q2	$7.12M	Sell	39,555 -978	-2%	-$168K	0.35%	48
2023 Q1	$7.54M	Sell	40,533 -10,618	-21%	-$1.87M	0.39%	45
2022 Q4	$8.45M	Sell	51,151 -2,300	-4%	-$384K	0.38%	53
2022 Q3	$8.27M	Sell	53,451 -1,140	-2%	-$191K	0.39%	46
2022 Q2	$8.39M	Sell	54,591 -1,452	-3%	-$244K	0.37%	54
2022 Q1	$10.3M	Sell	56,043 -75,309	-57%	-$13.3M	0.37%	52
2021 Q4	$24.8M	Sell	131,352 -3,233	-2%	-$621K	0.34%	47
2021 Q3	$25.9M	Sell	134,585 -4,526	-3%	-$863K	0.37%	43
2021 Q2	$26.8M	Buy	139,111 +2,655	+2%	+$498K	0.38%	42
2021 Q1	$25.8M	Sell	136,456 -7,183	-5%	-$1.25M	0.39%	46
2020 Q4	$23.6M	Sell	143,639 -5,998	-4%	-$933K	0.35%	48
2020 Q3	$21.4M	Sell	149,637 -6,531	-4%	-$888K	0.36%	48
2020 Q2	$19.8M	Sell	156,168 -26,774	-15%	-$3.12M	0.35%	53
2020 Q1	$18.3M	Sell	182,942 -2,614	-1%	-$314K	0.38%	51
2019 Q4	$23.8M	Sell	185,556 -758	-0.4%	-$93.5K	0.38%	48
2019 Q3	$24.1M	Sell	186,314 -1,851	-1%	-$228K	0.41%	42
2019 Q2	$21.6M	Buy	188,165 +8,650	+5%	+$967K	0.36%	49
2019 Q1	$19M	Sell	179,515 -8,762	-5%	-$908K	0.35%	57
2018 Q4	$17.8M	Sell	188,277 -2,758	-1%	-$267K	0.36%	52
2018 Q3	$20.5M	Sell	191,035 -5,237	-3%	-$582K	0.35%	51
2018 Q2	$21.6M	Buy	196,272 +303	+0.2%	+$32.8K	0.35%	52
2018 Q1	$20.4M	Sell	195,969 -143	-0.1%	-$15.5K	0.29%	52
2017 Q4	$20.5M	Sell	196,112 -316,639	-62%	-$30.8M	0.27%	54
2017 Q3	$46M	Sell	512,751 -9,318	-2%	-$766K	0.29%	57
2017 Q2	$40.2M	Sell	522,069 -10,805	-2%	-$866K	0.28%	62
2017 Q1	$42.9M	Sell	532,874 -7,249	-1%	-$561K	0.3%	58
2016 Q4	$39.4M	Sell	540,123 -18,880	-3%	-$1.35M	0.28%	61
2016 Q3	$39.2M	Sell	559,003 -7,402	-1%	-$505K	0.29%	64
2016 Q2	$35.5M	Sell	566,405 -8,362	-1%	-$497K	0.26%	68
2016 Q1	$33M	Sell	574,767 -13,581	-2%	-$721K	0.25%	69
2015 Q4	$32.2M	Sell	588,348 -13,326	-2%	-$744K	0.25%	76
2015 Q3	$29.8M	Sell	601,674 -17,527	-3%	-$855K	0.21%	87
2015 Q2	$31.9M	Sell	619,201 -3,848	-0.6%	-$212K	0.22%	87
2015 Q1	$35.6M	Sell	623,049 -12,522	-2%	-$703K	0.26%	79
2014 Q4	$34M	Sell	635,571 -8,932	-1%	-$452K	0.24%	88
2014 Q3	$30.7M	Sell	644,503 -16,677	-3%	-$799K	0.22%	96
2014 Q2	$31.6M	Sell	661,180 -35,473	-5%	-$1.66M	0.22%	92
2014 Q1	$32.8M	Sell	696,653 -16,445	-2%	-$726K	0.23%	89
2013 Q4	$31.3M	Sell	713,098 -17,487	-2%	-$732K	0.22%	93
2013 Q3	$29.4M	Sell	730,585 -10,555	-1%	-$410K	0.22%	90
2013 Q2	$25.8M	Buy	+741,140	New	+$26.5M	0.21%	93

Other funds holding TXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TXN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Texas Instruments (TXN) in Q2 2024, closing a stake of 36,674 shares — an estimated $6.39M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TXN in Q2 2013 and held it in 44 quarters. The position peaked at $46M in Q3 2017. 2,262 funds tracked by Wall St. Rank hold TXN as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Texas Instruments position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 36,674 Texas Instruments shares in Q2 2024, an estimated $6.39M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Texas Instruments in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Texas Instruments position peaked at $46M in Q3 2017.
2,262 funds tracked by Wall St. Rank held Texas Instruments as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.